← Back to Clinical Trials
Recruiting NCT07921212

NCT07921212 Effects of Telerehabilitation Versus Supervised Rehabilitation Protocol on Pain, Range of Motion and Functional Recovery in Patients With Patellofemoral Pain Syndrome.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07921212
Status Recruiting
Phase —
Sponsor Riphah International University
Condition Patello Femoral Pain Syndrome
Study Type INTERVENTIONAL
Enrollment 44 participants
Start Date 2026-10-15
Primary Completion 2026-12-15

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
TelerehabilitationSupervised Rehabilitation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 44 participants in total. It began in 2026-10-15 with a primary completion date of 2026-12-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to compare the effects of telerehabilitation and supervised rehabilitation protocols on pain, range of motion (ROM), and functional recovery in patients with Patellofemoral Pain Syndrome (PFPS). The findings will help determine the effectiveness of remote rehabilitation compared to conventional supervised physiotherapy in improving clinical outcomes among PFPS patients.

Eligibility Criteria

Inclusion Criteria: * • Participants aged 18-60 years * Anterior knee pain for at least 6 months. * Presence of retro-patellar or peri-patellar pain lasting more than 6 weeks. * Diagnosis of PFPS based on: Kujala score \< 100). Participants were included with PFPS when Kujala (AKPS) score \< 85 indicating limitation function limitation in PFPS. Positive Clarke's Test • Pain during patellar compression or patellar facet palpation Exclusion Criteria: * • History of knee injury/trauma or lower extremity joint replacement. * Systemic diseases: diabetes or rheumatoid arthritis. * Synovitis of the knee, degenerative osteoarthritis of the knee, and history of prior chronic knee pain. Having referred pain coming from the lumbar spine, hips, ankles or feet. * Athletes or individuals with high physical activity (based on GPAQ). * Neurological disorders

Contact & Investigator

Central Contact

Vaneeza Jamshaid, DPT

✉ malikawanvaneeza22@gmail.com

📞 03064542445

Principal Investigator

Vaneeza Jamshaid, DPT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07921212 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 60 Years, studying Patello Femoral Pain Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07921212 currently recruiting?

Yes, NCT07921212 is actively recruiting participants. Contact the research team at malikawanvaneeza22@gmail.com for enrollment information.

Where is the NCT07921212 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07921212 clinical trial?

NCT07921212 is sponsored by Riphah International University. The principal investigator is Vaneeza Jamshaid, DPT at Riphah International University. The trial plans to enroll 44 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology